Form 4: Sotera Health Director Receives Equity Grant

Director Sean Laurence Cunningham was granted 14,970 restricted stock units as part of the company's 2020 Omnibus Incentive Plan.

Summary

• Director Sean Laurence Cunningham received a grant of 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents the right to receive one share of common stock upon vesting.
• The RSUs vest in full on the earlier of the first anniversary of the grant date or the day before the next regular annual shareholders meeting.
• Following this transaction, the director's total beneficial ownership is 95,751 shares, consisting of 80,781 shares of common stock and 14,970 RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard retention mechanism for non-employee directors.

Negatives

• None identified.

Risks

• Vesting is subject to the director's continued service with the company.

Future Outlook

The RSUs are expected to vest in full by May 2027 or the date of the next annual shareholders meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the healthcare services sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant structure is consistent with standard equity compensation packages for directors in mid-cap healthcare companies.
• Vesting schedules tied to annual meetings are common practice among publicly traded firms to ensure board continuity.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard incentive grant.

Next Steps

• Vesting of the 14,970 RSUs on the earlier of May 22, 2027, or the day before the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Director Compensation, Equity Grant, Insider Ownership